Greka Anna bought OVID
June 15, 2026 · Form 4 insider transaction
Greka Anna bought 130,000 shares of Ovid Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
130,000
Price
$0.00
Total value
N/A
InsiderGreka Anna
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 15, 2026
Filing dateJune 17, 2026
Shares owned after130,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the stock option will vest in 36 equal monthly installments commencing on July 15, 2026, subject to the Reporting Person's continued services through each such date.